You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

Table 1.  

Characteristic No. (%)
Grantee organization type
State department of health 25 (86)
Tribal organization 4 (14)
Respondent role in CRCCP
Program director 12 (41)
Program manager 9 (31)
Program director and manager 3 (10)
Other 5 (17)
Length of respondent’s involvement in CRCCP
<1 year 4 (14)
12–23 months 3 (10)
24–35 months 4 (14)
≥3 years 18 (62)
Length of respondents’ involvement in cancer control, y
<1 2 (7)
1–3 4 (14)
4–5 2 (7)
≥6 21 (72)
Change in CRCCP’s program director or program manager during 2009–2015
Yes, the program manager changed 5 (17)
Yes, the program director changed 6 (21)
Yes, both changed 6 (21)
No, there has been no change in either the program director or program manager 12 (41)

Table 1. Grantee and Survey Respondent Characteristics (N = 29), Colorectal Cancer Control Program (CRCCP), 2015

Table 2.  

Category Program Year 2, 2011 (n = 28) Program Year 3, 2012 (n = 29) Program Year 4, 2013 (n = 28) Program Year 6, 2015 (n = 29)
Small media
No. of grantees implementing 27 28 28 25
No. grantees maintaining implementation 26 27 24
No. grantees discontinuing implementation 1 0 4
No. grantees newly implementing 1 1 0
Average ease of implementation (SD) 4.15 (1.08) 3.65 (0.75) 3.92 (0.80) 3.92 (0.86)
Client reminders
No. of grantees implementing 21 22 23 26
No. grantees maintaining implementation 19 19 21
No. grantees discontinuing implementation 2 2 2
No. grantees newly implementing 3 4 4
Average ease of implementation (SD) 3.95 (0.74) 3.50 (1.03) 3.29 (0.92) 3.31 (1.12)
Reducing structural barriers
No. of grantees implementing 14 17 23 23
No. grantees maintaining implementation 10 15 20
No. grantees discontinuing implementation 4 1 3
No. grantees newly implementing 6 8 2
Average ease of implementation (SD) 3.43 (1.16) 3.20 (1.08) 3.18 (0.96) 3.09 (1.00)
Provider reminders
No. of grantees implementing 9 11 19 19
No. grantees maintaining implementation 6 8 16
No. grantees discontinuing implementation 3 3 3
No. grantees newly implementing 5 11 2
Average ease of implementation (SD) 3.56 (0.73) 3.40 (1.26) 2.47 (0.83) 3.26 (1.10)
Provider assessment and feedback
No. grantees implementing 14 13 15 17
No. grantees maintaining implementation 5 9 13
No. grantees discontinuing implementation 9 3 2
No. grantees newly implementing 7 6 4
Average ease of implementation rating (SD) 3.71 (1.14) 3.10 (1.20) 1.92 (0.52) 2.53 (1.33)

Table 2. Evidence-based Intervention (EBI) Implementation, Ease of EBI Implementation,a and EBI Maintenance,b Colorectal Cancer Control Program, 2011–2015

Abbreviation: — , not applicable; SD, standard deviation.

 

a Respondents rated the ease of implementing the EBIs on a 5-point Likert scale (1 = very difficult, 5 = very easy).

b Maintenance is defined as responding, “Yes, we currently implement this EBI” in 2 consecutive administrations of this survey. In a few cases, grantees maintaining implementation could not be computed for a given grantee because they did not complete the grantee survey for the prior year. In these cases, the numbers for grantees maintaining implementation, grantees discontinuing implementation, and grantees newly implementing will sum to less than the total grantees implementing number for a given program year.

CME / ABIM MOC

Adoption and Implementation of Evidence-Based Colorectal Cancer Screening Interventions Among Cancer Control Program Grantees, 2009-2015

  • Authors: Peggy A. Hannon, PhD, MPH; Annette E. Maxwell, DrPH; Cam Escoffery, PhD, MPH; Thuy Vu, MPH; Marlana J. Kohn, MPH; Lindsay Gressard, MPH, MEd; Laurel Dillon-Sumner, MA; Caitlin Mason, PhD; Amy DeGroff, PhD, MPH
  • CME / ABIM MOC Released: 12/5/2019
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 12/5/2020
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care physicians, gastroenterologists, oncologists, and other physicians who care for patients at risk for colorectal cancer (CRC).

The goal of this activity is to evaluate the effects of a program designed to increase screening rates for CRC in clinical practice.

Upon completion of this activity, participants will:

  1. Evaluate the status of CRC screening in the United States
  2. Distinguish evidence-based intervention (EBI) used to promote CRC screening in the current study
  3. Identify the most popular EBI employed by practices to increase rates of CRC screening
  4. Assess the implementation and continuation of EBI to promote higher rates of CRC screening


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Peggy A. Hannon, PhD, MPH

    University of Washington
    Seattle, Washington

    Disclosures

    Disclosure: Peggy A. Hannon, PhD, MPH, has disclosed no relevant financial relationships.

  • Annette E. Maxwell, DrPH

    University of California, Los Angeles

    Disclosures

    Disclosure: Annette E. Maxwell, DrPH, has disclosed no relevant financial relationships.

  • Cam Escoffery, PhD, MPH

    Emory University
    Atlanta, Georgia

    Disclosures

    Disclosure: Cam Escoffery, PhD, MPH, has disclosed no relevant financial relationships.

  • Thuy Vu, MPH

    University of Washington
    Seattle, Washington

    Disclosures

    Disclosure: Thuy Vu, MPH, has disclosed no relevant financial relationships.

  • Marlana J. Kohn, MPH

    University of Washington
    Seattle, Washington

    Disclosures

    Disclosure: Marlana J. Kohn, MPH, has disclosed no relevant financial relationships.

  • Lindsay Gressard, MPH, MEd

    Centers for Disease Control and Prevention
    Atlanta, Georgia

    Disclosures

    Disclosure: Lindsay Gressard, MPH, Med, has disclosed no relevant financial relationships.

  • Laurel Dillon-Sumner, MA

    University of Washington
    Seattle, Washington

    Disclosures

    Disclosure: Laurel Dillon-Sumner, MA, has disclosed no relevant financial relationships.

  • Caitlin Mason, PhD

    University of Washington
    Seattle, Washington

    Disclosures

    Disclosure: Caitlin Mason, PhD, has disclosed no relevant financial relationships.

  • Amy DeGroff, PhD, MPH

    Centers for Disease Control and Prevention
    Atlanta, Georgia

    Disclosures

    Disclosure: Amy DeGroff, PhD, MPH, has disclosed no relevant financial relationships.

CME Author

  • Charles P. Vega, MD

    Health Sciences Clinical Professor of Family Medicine
    University of California, Irvine School of Medicine

    Disclosures

    Disclosure: Charles P. Vega, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Genentech, Inc.; GlaxoSmithKline
    Served as a speaker or a member of a speakers bureau for: Shire

Editor

  • Caran Wilbanks

    Editor
    Preventing Chronic Disease

    Disclosures

    Disclosure Caran Wilbanks has disclosed the following relevant financial relationships:
    Other: Partner is employed by Allscripts Healthcare, LLC

CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships. 


Accreditation Statements


 

In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Preventing Chronic Disease. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team..

    For Physicians

  • Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Adoption and Implementation of Evidence-Based Colorectal Cancer Screening Interventions Among Cancer Control Program Grantees, 2009-2015

Authors: Peggy A. Hannon, PhD, MPH; Annette E. Maxwell, DrPH; Cam Escoffery, PhD, MPH; Thuy Vu, MPH; Marlana J. Kohn, MPH; Lindsay Gressard, MPH, MEd; Laurel Dillon-Sumner, MA; Caitlin Mason, PhD; Amy DeGroff, PhD, MPHFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 12/5/2019

Valid for credit through: 12/5/2020

processing....

Abstract

Purpose and Objectives

Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States. Although effective CRC screening tests exist, CRC screening is underused. Use of evidence-based interventions (EBIs) to increase CRC screening could save many lives. The Colorectal Cancer Control Program (CRCCP) of the Centers for Disease Control and Prevention (CDC) provides a unique opportunity to study EBI adoption, implementation, and maintenance. We assessed 1) the number of grantees implementing 5 EBIs during 2011 through 2015, 2) grantees’ perceived ease of implementing each EBI, and 3) grantees’ reasons for stopping EBI implementation.

Intervention Approach

CDC funded 25 states and 4 tribal entities to participate in the CRCCP. Grantees used CRCCP funds to 1) provide CRC screening to individuals who were uninsured and low-income, and 2) promote CRC screening at the population level. One component of the CRC screening promotion effort was implementing 1 or more of 5 EBIs to increase CRC screening rates.

Evaluation Methods

We surveyed CRCCP grantees about EBI implementation with an online survey in 2011, 2012, 2013, and 2015. We conducted descriptive analyses of closed-ended items and coded open-text responses for themes related to barriers and facilitators to EBI implementation.

Results

Most grantees implemented small media (≥25) or client reminders (≥21) or both all program years. Although few grantees reported implementation of EBIs such as reducing structural barriers (n = 14) and provider reminders (n = 9) in 2011, implementation of these EBIs increased over time. Implementation of provider assessment and feedback increased over time, but was reported by the fewest grantees (n = 17) in 2015. Reasons for discontinuing EBIs included funding ending, competing priorities, or limited staff capacity.

Implications for Public Health

CRCCP grantees implemented EBIs across all years studied, yet implementation varied by EBI and did not get easier with time. Our findings can inform long-term planning for EBIs with state and tribal public health institutions and their partners.

Introduction

Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States [1]. The US Preventive Services Task Force (USPSTF) recommends CRC screening for average risk adults, aged 50 to 75 years, using either stool-based tests (ie, fecal occult blood test [FOBT], fecal immunochemical test [FIT], or multitargeted stool DNA test [FIT-DNA]) or tests that directly visualize the colon (ie, colonoscopy, sigmoidoscopy, or computed tomographic colonography) [2]. However, CRC screening is underused; estimates of screening rates in the United States range from 63% (National Health Interview Survey, 2015) to 68% (Behavioral Risk Factor Surveillance System, 2016) [3, 4]. CRC screening rates are substantially lower for populations without health insurance, populations without a medical home, and Asian and Pacific Islander and Hispanic populations [3, 5, 6]. Increasing CRC screening rates to 80% has the potential to prevent 277,000 CRC cases and 203,000 CRC deaths by 2030 [3], partly because CRC screening has the potential not only to detect cancer early but also to prevent it through the identification and removal of precancerous polyps. Many organizations support the “80% in Every Community” initiative, which established the goal of 80% of the total population of adults aged 50 to 75 years being up to date for CRC screening.

The Colorectal Cancer Control Program (CRCCP) is a CDC initiative to increase CRC screening among adults aged 50 to 75. The program’s grantees — most often state health departments and tribal health agencies — are funded (in part) to promote CRC screening by using 5 evidence-based interventions (EBIs). We focus on the first cycle of the CRCCP from 2009 through 2015, which funded 29 grantees. The evaluation activities we describe were conducted from 2011 through 2015.

Purpose and Objectives

The CRCCP provides a unique opportunity to study EBI adoption, implementation, and maintenance over several years in a stable group of grantee organizations and in the context of a national program. Few studies examine EBI implementation among the same organizations longitudinally over the course of 5 years or more [8, 9]. We studied grantees’ early experiences with adopting and implementing EBIs and compared their experiences with National Breast and Cervical Cancer Early Detection Program (NBCCEDP) grantees that did not receive CRCCP funding and were not explicitly directed to use EBIs [10–13]. Grantees and nongrantees were equally likely to implement practices that are not recommended by the Guide to Community Preventive Services (Community Guide), but grantees were more likely to implement EBIs [13]. This finding showed that CDC’s encouragement and financial support to the grantees to use these EBIs was effective, because all grantees were using at least 1 or 2 EBIs by the end of the second program year. The intended contribution of this study is to determine whether grantees maintained the EBIs they implemented over time and why (or why not). We assessed 1) how many grantees implemented each EBI from 2009 through 2015; 2) grantees’ perceived ease of implementing each EBI; 3) the maintenance of specific EBIs from year to year; and 4) qualitative data describing why grantees stopped using EBIs as well as facilitators and barriers to implementing EBIs.

Intervention Approach

CDC’s Division of Cancer Prevention and Control initially funded the CRCCP in 2009. The overall goal of CRCCP was to increase CRC screening rates to 80% in funded states and tribal areas by the end of the funding cycle, with a long-term objective of reducing CRC incidence and mortality. In 2009, a total of 22 states and 4 tribal entities were awarded CRCCP funds; an additional 3 states received CRCCP funds in 2010. All grantees’ awards lasted through June 2015 [7].

Grantees used CRCCP funds for 2 program components. First, grantees provided CRC screening services to low-income and uninsured people in their region. Second, grantees promoted CRC screening at the population level. Grantees were strongly encouraged to use 1 or more of 5 EBIs from the Community Guide to promote CRC screening (grantees were free to choose any combination of the EBIs to implement and could change their choices over time). The Community Guide conducts systematic reviews of evidence to identify effective strategies to increase cancer screening and other health desirable behaviors [14]. Three of the EBIs are classified as “client-oriented,” meaning they focus on the person needing screening; these EBIs are small media (such as brochures, postcards, or posters), client reminders, and reducing structural barriers. Two of the EBIs are classified as “provider-oriented,” meaning they increase the likelihood that providers will recommend screening; these EBIs are provider reminders and provider assessment and feedback [15, 16]. In addition, CDC encouraged grantees to use patient navigation; the NIH state-of-the-science conference statement on enhancing the use and quality of CRC screening recommends patient navigation as an evidence-based strategy for CRC screening [17].

The EBIs listed above vary in terms of complexity and partnerships required. The client-oriented EBIs could be implemented directly by grantees or by their clinical or community partners. The provider-oriented EBIs may be more complex from the perspective of a typical grantee organization because they require 1 or more clinic or health system partners. In addition, implementing provider reminders or provider assessment and feedback may require working with or adapting electronic health records. Given the grantees’ organizational context (state and tribal departments of health), the provider-oriented EBIs may be more challenging to implement than the client-oriented EBIs.

A key assumption underlying the CRCCP is that if grantees implement EBIs, CRC screening rates will increase. The evaluation described below focused on whether grantees implemented and maintained EBIs over the funding cycle (measured with quantitative survey items) and barriers and facilitators to implementing and maintaining EBIs (measured with open-text survey responses).